Viewing Study NCT06377306



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06377306
Status: RECRUITING
Last Update Posted: 2024-04-22
First Post: 2024-01-31

Brief Title: Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes
Sponsor: Wingate Institute
Organization: Wingate Institute

Study Overview

Official Title: Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes Using Measures of Strength Fatigue Injury Psychological Parameters Serum Circulating Metabolites and the Intestinal Microbiome
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Despite a rise in the number of women participating in competitive sports there remains a gender gap within sport and exercise science literature Studying females involves potential noise through the change in hormone concentrations during the different phases of the female menstrual cycle MC which can potentially affect physiological parameters thereby making study design and interpretation of findings difficult Longitudinal data on the acute and chronic combined effects of training load and MC phases on circulating female hormones in elite and non-elite female athletes is lacking

The investigators aim to characterize and track the potential effects of training load and MC phases on performance anthropometric measures sport emotions intestinal microbiome serum metabolites and injury prevalence in elite and non-elite female athletes

200 competitive premenopausal female athletes will be recruited In a longitudinal observational design each participant will be followed for 1 year and tested at three time points At each point data will be collected on two occasions reflecting distinct phases of the MC

Finding the possible relationship between the MC phases training load and performance or specific bio-markers for training load are of utmost importance and can assist professionals to identify periods of high load and over-training thus preventing injuries and training adjustment
Detailed Description: The purpose of the current investigation is threefold

1 To evaluate the prevalence of menstruation and menstrual related issues among elite and non-elite female athletes
2 To identify physical- and bio-markers holding information about training load among elite and non-elite female athletes using sets of performance measures hormonal responses metabolites in the blood and intestinal microbiome
3 To track and characterize the association of training load with a variety of performance eg force flexibility endurance etc and anthropometric measures sports emotions and affect rate of perceived exertion RPE and injury prevalence in women with different training status elite and non-elite

Methods Participants will be tested at three distinct time points that will reflect the different training loads low moderate high during a year of follow up

Elite athletes will be tested at 1 low load phase baseline 2 Moderate training phase prior to competition 3 High after training camps or during competitions period

Testing for each phase will be scheduled for at least two weeks after the beginning of the phase andor when at least 50 of the duration of the phase is completed This is to allow for accumulation of training load and phase fatigue or recovery

Since non elite athletes usually do not follow a periodized training program they will be tested at three time points during the year The Investigators will similarly aim that these time points will reflect different training loads low moderate and high

Study description Elite athletes will be recruited through elite athletes coaches and unions and advertisement using flyers and social media Non-elite athlete will be recruited through advertisements at Wingate institute and social media

They will be asked to arrive to a meeting at Wingate institute in which they will receive an explanation about the study by the authorized physician and will sign an informed consent form

After enrollment each athlete in the elite group and coach in the case of an athlete that is part of a team and non-elite group will meet with one of the investigators to go over their yearly training plan to characterize past and present training history and to establish training phases and schedule individual testing sessions

The menstrual status of each athlete will be considered when designing the testing schedule see blood tests below

During each of the three assessment periods low moderate high the athletes will perform the following tests mentioned in study procedures The Study procedures will be done in addition to the routine follow-up of each athlete

Study procedures Questionnaires

Participants will be asked to fill the following questionnaires

Questionnaire 1 -medical history women health and physical activity Questionnaire 2- Food frequency Questionnaire FFQ Questionnaire 3- Psychological aspects of competition Questionnaire 4- A wellness questionnaire to be filled on each Training load quantification

Each questionnaire will be filled three times yearly at each of the designated three time periods The questionnaires will be filled via specific online app designated for research purposes

Menstrual records During the 12-month period subjects will be instructed to keep a menstrual calendar using a designated smartphone application to estimate the length of the cycle They will be asked to record the date of the menses length of menses severity of blood flow and any discomfort if it exists

Blood tests will be drawn by authorized and trained study personal between 800 - 1000 AM after an 8-hour fast 3 hours of awakens and without any morning training that day Participants will be asked to avoid taking any medications at the morning of the tests and any supplements three days before the tests

The blood parameters that will be evaluated are the following 25OHD albumin cortisol insulin glucose TSH FT4 FT3 total testosterone testosterone free SHBG GH IGF1 In addition two aliquots of serum will be frozen for future potential analysis An additional chemistry tube will be taken for serum metabolites to be analyzed at the Elinav Lab see below

Tubes will be centrifuged and serumplasma will be frozen at -20 degrees until further analysis at a certified Lab and the Elinav Lab

The following schedule for blood tests will be employed

In athletes reporting regular cycles blood tests will be performed during the follicular phase in days 3-5 of the cycle and again during the luteal phase during days 21-22 These time points were chosen since they represent two occasions where hormones contrast at their greatest magnitude Participants will alert the researchers on the first day of bleeding and then the 1st session of testing will occur within 3-5 days

In athletes reporting menses intervals above 35 days or less than nine menstrual cycles per year or if data is unknown - blood tests will be performed three times a year during the different training phases

Likewise blood tests will be performed in regular intervals for those athletes using oral contraceptives

Targeted and untargeted serum metabolomics An untargeted high-performance liquid-chromatography mass-spectrometry is used to characterize the small molecules profile in fecalplasma samples ie metabolomics This method identifies different small molecules in a homogenized tissue lysate by simultaneously assessing their molecular weight and electrical charge In short a tissue extract is divided into five fractions one is saved as backup and the rest are analyzed in 4 protocols to identify polar semi-polar lipid and volatile metabolites Signals are mapped to a known metabolomic database filtered to optimize signal-to-noise ratio and normalized Analysis of clustering and differential abundance then follow to identify candidate key-metabolites that may be correlate with the diseasecondition

Stool microbiome Participants will receive kits in order to collect stool samples at home and store it in their home freezers until they will be delivered to the Elinav lab at the Weizmann Institute where they will be stored encoded at -80C with no identifying information and examined later on

For microbiome characterization the investigators will perform whole-genome shotgun metagenomics sequencing a technique that enables sampling all genes in all organisms present in each sample including unknown unculturable bacteria Genetic material is purified from a human microbiome sample and broken down to short fragments that can be sequenced on a large scale in parallel By comparing these sequences to databases of known microbial genomes The investigators can characterize the microbial diversity of the sample which bacteria are present and their abundances including high-resolution identification of distinct bacterial strains Using gene abundances The investigators can reconstruct metabolic pathways and describe the functional capacities of the microbial community that potentially contribute to the phenotype of interest

Performance Testing procedures Performance measures covering a broad array of general physical abilities will include the following tests maximal aerobic capacity - VO2max test explosive power - countermovement jump CMJ flexibility - sit and reach and ankle dorsiflexion range of motion strength - maximal voluntary isometric hand grip test IGT and isokinetic strength during knee extension KE and flexion KF and kinematic analysis of frontal plane projection angle FPPA as a measure of knee valgus

Injury Monitoring The investigators will record the prevalence of injuries sustained during the study Injuries will be documented according to the International Olympic Committee consensus guidelines Injuries will be classified according to onset severity mechanism of injury body area injured and diagnosis of injury An injury surveillance questionnaire will be completed by the relevant medical professional working with the athletes as part of the routine follow-up of the athletes

Training load quantification and wellness The athletes will be instructed to report all their training and competitions during the duration of the study Endurance athletes will be encouraged to use a Garmin watch and an online training monitoring interface TrainingPeaks or Garmin Connect Acute training load ATL will be calculated as the load during the 7 days preceding each assessment date both as accumulated and average training hours intensity levels time in different training zones and possibly total and average power or distance covered based on the athletes individual sport Chronic training load CTL will be defined as the accumulated load for the 4 weeks preceding each assessment date

In sports in which no objective measurable data exists eg team sports combat sports etc the internal load will be quantified based on the session RPE sRPE and the athlete will be asked to keep a training diary and report their training sessions At the end of each training session the athletes will be asked to subjectively rate the intensity of the entire training session using the category Borg scale CR-10 The RPE value will then be multiplied by the total duration min of the training session In the non-elite group the athletes will be encouraged to keep a training diary and report their training duration distance type of training and rate the intensity of the training session based on the Borg scale

The participants will be asked to fill a Wellness status using a subjective wellness questionnaire The questionnaire is composed of 6 questions evaluating athletes fatigue stress sleep quality muscle soreness illness and desire to train on a 7-point scale 1 very very bad 7 very very good The participants will be asked to fill the questionnaire on a daily basis 2-3 weeks preceding each assessment date

Anthropometric measures will be done at each of the designated time periods Height cm and body mass kg will be measured using a stadiometer and a digital scale respectively and will be recorded to the nearest 01 cm and 01 kg respectively Body composition body fat and lean body mass kg will be evaluated using Dual-Energy X-ray Absorptiometry DEXA

Food intake diary - energy availability On top of the FFQ athletes will receive a detailed explanation on how to record a daily food diary from the investigators Energy availability will be defined as the amount of dietary energy remaining for other bodily functions after exercise training Dietary energy will be calculated in each subject from a prospective 3-day food diary prior to each assessment session using a Nutrient Analysis program All subjects will meet with the same registered dietitian and explanations will be given on how to complete the intake eg portion sizes and ounces of liquid consumed Subjects will be encouraged to weigh portion sizes Energy expenditure will be calculated from duration of sports participation intensity of exercise weight age and sex from the Ainsworth compendium of physical activity Energy availability will be expressed as kcalkg lean body mass energy balance will be considered 45 kcalkg-1 FFMd-1 in healthy young women and low energy availability will be defined as energy availability 45 kcalLBM If the dietitian will realize that the food diary completed by the participant is not reliable or data is missing a 24hr food and hydration recall will be completed

Psychological parameters Emotions and affect Participants will be asked to a questionnaire which will measure their general affect and their specific emotions related to a specific event and precompetitive emotion Two primary general dimensions of mood positive and negative affect will be measured by using the Positive-Affect Negative-Affect Scale and the Sport Emotion Questionnaire is a sport-specific measure of precompetitive emotion grounded in the experience of athletes assessing anger anxiety dejection excitement and happiness

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None